Sun Pharma introduces Ilumya in India for treatment of plaque psoriasis
Ilumya is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials
Ilumya is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials
Renalyx will continue operating as an independent unit within the group
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
Several technologies for hemoglobinopathies are being transferred to commercial partners
India currently hosts more than 10,075 biotech startups
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
Subscribe To Our Newsletter & Stay Updated